The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Total net sales | 2,527,900 |
| Segment cost of goods sold | 2,256,700 |
| Ira credit | -89,100 |
| Lower of cost or nrv inventory adjustment | 8,600 |
| Property and equipment expense | 95,300 |
| Selling, general and administrative expenses | 79,900 |
| Other operating expenses - net | -18,400 |
| Interest expense-Nonrelated Party | 41,900 |
| Interest expense-Related Party | 5,800 |
| Interest income | 9,200 |
| Net gain (loss) on forward and derivative contracts-Nonrelated Party | -94,700 |
| Net gain (loss) on forward and derivative contracts-Related Party | 0 |
| Loss on early extinguishment of debt | -7,700 |
| Bargain purchase gain | 0 |
| Other expense - net | -14,500 |
| Income tax benefit (expense) | -13,100 |
| Equity in earnings (losses) of joint ventures | 0 |
| Net income (loss) | 15,800 |
| Unrealized loss (gain) on derivative instruments | -62,800 |
| Depreciation, depletion and amortization | 91,800 |
| Share-based compensation | 47,000 |
| Loss on early extinguishment of debt | -7,700 |
| Change in deferred tax provision | -13,700 |
| Gain on sale of assets | 0 |
| Bargain purchase gain | 0 |
| Force majeure settlement | 0 |
| Lower of cost or nrv inventory adjustment | 8,600 |
| Net periodic benefit cost | 12,100 |
| Other non-cash items - net | -7,400 |
| Accounts receivable - net | 24,000 |
| Non-trade receivables | 2,100 |
| Manufacturing credit receivable | 20,700 |
| Due from affiliates | 4,500 |
| Inventories | -10,800 |
| Prepaid and other current assets | -3,800 |
| Accounts payable, trade | 1,400 |
| Due to affiliates | -13,200 |
| Accrued and other current liabilities | 11,600 |
| Ravenswood retiree medical settlement | -2,000 |
| Pbgc settlement | -2,400 |
| Other - net | 13,200 |
| Net cash provided by (used in) operating activities | 185,000 |
| Capital expenditures | 100,200 |
| Proceeds from sale of property, plant and equipment | 0 |
| Acquisition of subsidiary net of cash acquired | 0 |
| Net cash used in investing activities | -100,200 |
| Repayment of senior notes due 2028 | 250,000 |
| Early redemption premiums paid | 4,700 |
| Proceeds from issuance of senior notes due 2032 | 400,000 |
| Payment of deferred financing fees | 6,300 |
| Borrowings under revolving credit facilities-U.S.And Iceland Revolving Credit Facilities | 883,200 |
| Repayments under revolving credit facilities-U.S.And Iceland Revolving Credit Facilities | 876,100 |
| Repayments under revolving credit facilities-Iceland Term Facility | 0 |
| Borrowings under facility agreements-Casthouse Facility | 0 |
| Repayments under grundartangi casthouse debt facility-Casthouse Facility | 123,200 |
| Borrowings under facility agreements-Vlissingen Credit Facility | 0 |
| Repayments under revolving credit facilities-Vlissingen Credit Facility | 10,000 |
| Contributions from joint venture partner | 19,900 |
| Payments related to tax withholding for share-based compensation | 17,500 |
| Carbon credit proceeds | 28,100 |
| Carbon credit repayments | 28,300 |
| Net cash provided by (used in) financing activities | 15,100 |
| Change in cash, cash equivalents, and restricted cash | 99,900 |
| Cash, cash equivalents and restricted cash, beginning of year | 35,700 |
| Cash, cash equivalents and restricted cash, end of year | 135,600 |
CENTURY ALUMINUM CO (CENX)
CENTURY ALUMINUM CO (CENX)